Annual Shareholders Equity
-$99.23 M
-$225.87 M-178.36%
31 December 2023
Summary:
Atara Biotherapeutics annual stockholders equity is currently -$99.23 million, with the most recent change of -$225.87 million (-178.36%) on 31 December 2023. During the last 3 years, it has fallen by -$561.57 million (-121.46%). ATRA annual shareholders equity is now -121.46% below its all-time high of $462.34 million, reached on 31 December 2020.ATRA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$90.54 M
+$20.33 M+18.34%
30 September 2024
Summary:
Atara Biotherapeutics quarterly stockholders equity is currently -$90.54 million, with the most recent change of +$20.33 million (+18.34%) on 30 September 2024. Over the past year, it has dropped by -$39.70 million (-78.09%). ATRA quarterly shareholders equity is now -119.58% below its all-time high of $462.34 million, reached on 31 December 2020.ATRA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -178.4% | -78.1% |
| 3 y3 years | -121.5% | -129.2% |
| 5 y5 years | -129.3% | -128.4% |
ATRA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -121.5% | at low | -129.2% | +18.3% |
| 5 y | 5 years | -121.5% | at low | -119.6% | +18.3% |
| alltime | all time | -121.5% | at low | -119.6% | +18.3% |
Atara Biotherapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$90.54 M(-18.3%) |
| June 2024 | - | -$110.87 M(+12.8%) |
| Mar 2024 | - | -$98.31 M(-0.9%) |
| Dec 2023 | -$99.23 M(-178.4%) | -$99.23 M(+95.2%) |
| Sept 2023 | - | -$50.84 M(-782.0%) |
| June 2023 | - | $7.45 M(-88.5%) |
| Mar 2023 | - | $64.96 M(-48.7%) |
| Dec 2022 | $126.64 M(-54.7%) | $126.64 M(-32.3%) |
| Sept 2022 | - | $187.11 M(-27.3%) |
| June 2022 | - | $257.48 M(+14.8%) |
| Mar 2022 | - | $224.32 M(-19.8%) |
| Dec 2021 | $279.61 M(-39.5%) | $279.61 M(-9.8%) |
| Sept 2021 | - | $310.14 M(-6.5%) |
| June 2021 | - | $331.54 M(-16.9%) |
| Mar 2021 | - | $399.04 M(-13.7%) |
| Dec 2020 | $462.34 M(+59.0%) | $462.34 M(+30.6%) |
| Sept 2020 | - | $353.94 M(-7.1%) |
| June 2020 | - | $381.13 M(+50.7%) |
| Mar 2020 | - | $252.82 M(-13.1%) |
| Dec 2019 | $290.78 M | $290.78 M(-8.7%) |
| Sept 2019 | - | $318.44 M(+37.1%) |
| June 2019 | - | $232.28 M(-18.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $283.93 M(-16.2%) |
| Dec 2018 | $338.86 M(+90.5%) | $338.86 M(-15.9%) |
| Sept 2018 | - | $403.05 M(-10.9%) |
| June 2018 | - | $452.50 M(+3.0%) |
| Mar 2018 | - | $439.18 M(+146.9%) |
| Dec 2017 | $177.86 M(-29.9%) | $177.86 M(-13.6%) |
| Sept 2017 | - | $205.96 M(-6.9%) |
| June 2017 | - | $221.14 M(-5.1%) |
| Mar 2017 | - | $233.13 M(-8.1%) |
| Dec 2016 | $253.74 M(-19.5%) | $253.74 M(-6.1%) |
| Sept 2016 | - | $270.20 M(-6.9%) |
| June 2016 | - | $290.25 M(-4.5%) |
| Mar 2016 | - | $303.83 M(-3.6%) |
| Dec 2015 | $315.10 M(+205.4%) | $315.10 M(-5.6%) |
| Sept 2015 | - | $333.75 M(+123.6%) |
| June 2015 | - | $149.25 M(-10.1%) |
| Mar 2015 | - | $166.09 M(+61.0%) |
| Dec 2014 | $103.18 M(-1036.6%) | $103.18 M(-548.1%) |
| Sept 2014 | - | -$23.03 M(-141.0%) |
| June 2014 | - | $56.22 M(-482.4%) |
| Mar 2014 | - | -$14.70 M(+33.5%) |
| Dec 2013 | -$11.02 M(+195.6%) | -$11.02 M |
| Dec 2012 | -$3.73 M | - |
FAQ
- What is Atara Biotherapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual shareholders equity year-on-year change?
- What is Atara Biotherapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly shareholders equity year-on-year change?
What is Atara Biotherapeutics annual stockholders equity?
The current annual shareholders equity of ATRA is -$99.23 M
What is the all time high annual shareholders equity for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual stockholders equity is $462.34 M
What is Atara Biotherapeutics annual shareholders equity year-on-year change?
Over the past year, ATRA annual stockholders equity has changed by -$225.87 M (-178.36%)
What is Atara Biotherapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ATRA is -$90.54 M
What is the all time high quarterly shareholders equity for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly stockholders equity is $462.34 M
What is Atara Biotherapeutics quarterly shareholders equity year-on-year change?
Over the past year, ATRA quarterly stockholders equity has changed by -$39.70 M (-78.09%)